Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01335009
Recruitment Status : Active, not recruiting
First Posted : April 13, 2011
Last Update Posted : March 7, 2017
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : December 2, 2013
  Estimated Study Completion Date : December 2017
  Certification/Extension First Submitted : June 25, 2015